Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma (EQUI-HIPPO)

Toulouse University Hospital

Status: Enrolling

Conditions: Neuroblastoma

Treatments: Other: horse therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT05755295

RC31/22/0218

Details and patient eligibility

About

On average, each year in the former region, 60 new patients under the age of 18 are treated for a brain tumor, with an active post-treatment follow-up file of 350 patients. Because of the significant sequelae induced by the disease or the treatments, these patients will very often require rehabilitative care.

The interest of involving the horse in the population of patients cured of a medulloblastoma but with important physical and psychological after-effects is to be able to combine a therapy using animal mediation (equitherapy) and a rehabilitation therapy based on the three-dimensional movement of the horse (hippotherapy).

Enrollment: 15 estimated patients

Sex: All

Ages: 10 to 26 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• complete remission of medulloblastoma and after 5 years of the end of treatment
• living within 30 km away the riding center and/or less than 1 hour of transport
• informed consent

Exclusion criteria

• Landsky score below 50% for minors until 16 years old and Karnofsky score below 50% for patients over 16 years
• major under juridical protection

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 1 patient group

horse therapy

Experimental group

Treatment:

Other: horse therapy